NHS guidance describes an initial phase that can be every other day for 2 weeks (or until symptoms improve).Maintenance schedules are often every 23 months in appropriate long-term cases

Manufactured for: Revised: November 2025 PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Vial Label - 1 mL: NDC 87188-111-01 Rx Only Cyanocobalamin Injection, USP 1,000 mcg/mL For Intramuscular or Subcutaneous Use Only 1 mL Multiple-Dose Vial Carton Label - 1 mL: NDC 87188-111-90 Rx Only Cyanocobalamin Injection, USP 1,000 mcg/mL For Intramuscular or Subcutaneous Use Only 25 X 1 mL Multiple-Dose Vials Vial Label - 10 mL: NDC 87188-112-01 Rx Only Cyanocobalamin Injection, USP 10,000 mcg/10 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 10 mL Multiple-Dose Vial Carton Label - 10 mL: NDC 87188-112-01 Rx Only Cyanocobalamin Injection, USP 10,000 mcg/10 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 1 x 10 mL Multiple-Dose Vial Vial Label - 30 mL: NDC 87188-113-01 Rx Only Cyanocobalamin Injection, USP 30,000 mcg/30 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 30 mL Multiple-Dose Vial Carton Label - 30 mL: NDC 87188-113-01 Rx Only Cyanocobalamin Injection, USP 30,000 mcg/30 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 1 x 30 mL Multiple-Dose Vial More about cyanocobalamin Check interactions Compare alternatives Pricing & coupons Reviews (31) Drug images Side effects Dosage information During pregnancy Drug class: vitamins

Frequently Asked Questions What do the gauge and length numbers on a GLP-1 pen needle actually mean
FDA compounding review On December 4, 2024, the FDA Pharmacy Compounding Advisory Committee (PCAC) reviewed AOD-9604 (free base) and AOD-9604 acetate against the 503A Bulks List
Activation of this pathway is associated with hair growth initiation